Prolonged survival of patients receiving trastuzumab beyond disease progression for HER2 overexpressing metastatic breast cancer (MBC) [PDF]
Background: The aim of this retrospective analysis was to evaluate the impact of trastuzumab-based regimens on the survival of patients with HER2-overexpressing metastatic breast cancer (MBC).
Heinrich, B. +5 more
core +1 more source
Building trajectories through clinical data to model disease progression [PDF]
This thesis was submitted for the degree of Doctor of Philosophy and awarded by Brunel University.Clinical trials are typically conducted over a population within a defined time period in order to illuminate certain characteristics of a health issue or ...
Li, Yuanxi
core +5 more sources
Statistical Disease Progression Modeling in Alzheimer Disease [PDF]
BACKGROUND: The characterizing symptom of Alzheimer disease (AD) is cognitive deterioration. While much recent work has focused on defining AD as a biological construct, most patients are still diagnosed, staged, and treated based on their cognitive ...
Alzheimer's Disease Neuroimaging Initiative +1 more
core +1 more source
Progress in Huntington’s disease: the search for markers of disease onset and progression [PDF]
Unlike most neurodegenerative disorders, individuals at risk from Huntington's disease can be identified prior to the onset of clinical signs of the disease by virtue of it being an autosomal dominant condition. This provides the hypothetical opportunity to delay disease onset and/or slow down the progression of the disease in the very early stages ...
Mason, Sarah, Barker, Roger A
openaire +2 more sources
Timing of progression from Chlamydia trachomatis infection to pelvic inflammatory disease: a mathematical modelling study. [PDF]
BACKGROUND: Pelvic inflammatory disease (PID) results from the ascending spread of microorganisms from the vagina and endocervix to the upper genital tract. PID can lead to infertility, ectopic pregnancy and chronic pelvic pain. The timing of development
Herzog, Sereina A +35 more
core +5 more sources
FoxO3a and disease progression
The Forkhead box O (FoxO) family has recently been highlighted as an important transcriptional regulator of crucial proteins associated with the many diverse functions of cells. So far, FoxO1, FoxO3a, FoxO4 and FoxO6 proteins have been identified in humans.
Richard Seonghun, Nho, Polla, Hergert
openaire +2 more sources
Metabolome in progression to Alzheimer's disease [PDF]
Mild cognitive impairment (MCI) is considered as a transition phase between normal aging and Alzheimer's disease (AD). MCI confers an increased risk of developing AD, although the state is heterogeneous with several possible outcomes, including even improvement back to normal cognition.
Hyötyläinen, Tuulia +14 more
openaire +4 more sources
CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. [PDF]
Age-related macular degeneration (AMD) is a prevalent cause of blindness in Western societies. Variants in the genes encoding complement factor H (CFH), complement component 3 (C3) and age-related maculopathy susceptibility 2 (ARMS2) have repeatedly been
Weber, Bernhard H. F. +68 more
core +2 more sources
Targeting the Progression of Parkinsons Disease [PDF]
By the time a patient first presents with symptoms of Parkinson's disease at the clinic, a significant proportion (50-70%) of the cells in the substantia nigra (SN) has already been destroyed. This degeneration progresses until, within a few years, most of the cells have died.
George, JL +6 more
openaire +3 more sources
Impact of immune activation and inflammation on the susceptibility to HIV infection and disease progression in HIV serodiscordant and seroconcordant couples [PDF]
Includes bibliographical references.The biological correlates of protection against HIV infection remain poorly characterized, hindering the development of an effective prevention strategy. Studies of individuals who resist HIV infection or progress more
Jaumdally, Shameem Zaer
core +1 more source

